TABLE 1.
Treatment | N | Total cell count (×105) | AM (X105) | LYM (×105) | PMN (×105) | |
C57Bl/6 | PBS/Surf | 10 | 8.0 ± 2.9 | 7.7 ± 2.8 [97] | 0.3 ± 0.3 [3] | 0.06 ± 0.09 [1] |
C57Bl/6 | MWCNT | 10 | 9.8 ± 2.5 | 8.9 ± 2.0 [92] | 0.7 ± 0.5 [6] | 0.2 ± 0.2 [2] |
Mmp12 KO | PBS/Surf | 10 | 7.7 ± 2.5 | 7.5 ± 2.5 [97] | 0.1 ± 0.1 [2] | 0.05 ± 0.1 [1] |
Mmp12 KO | MWCNT | 10 | 12.0 ± 4.1* | 11.1 ± 4.0 [92]* | 0.4 ± 0.2 [4] | 0.5 ± 0.4 [4]* |
AM, alveolar macrophages; LYM, lymphocytes; PMN, neutrophils. *Means ± SD, p ≤ 0.05 compared to PBS/Surf vs MWCNT in MMP12 KO. [ ] Percentage.